CLINICAL_TRIALS
trial_result
· 2024-05-20
Clinical Trial Update: Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017) [Phase 2]
Summary
Phase 2 RSV human challenge study MK-4482-017 in healthy participants has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Respiratory Syncytial Virus | Phase 2 | Status: COMPLETED | Results posted: 2024-05-20